Skip to main content

Table 3 Categorical variables of renal transplant recipients, 1 July 1994–30 June 1998A

From: Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States

Factor

Renal Transplant recipients

Missing, N (%)

N with valid Followup times

  

Male Recipient (female)

23,827 (60.1)

0

African American (all other races)

9142 (23.1)

640 (1.5)

Graft lossB (Absent)

2815 (6.5%)

0

Cadaveric Donor (living donor)

27,369 (69.1)

0

Quartiles of Age (vs. >55 years)

  

<33

  

33–44

  

45–55

  

Diabetes as a comorbidity at listing (vs. absent)

7977 (24.7)

9931 (23.3)

History of Peritoneal Dialysis (vs. Hemodialysis)

8260 (19.6)

7855 (18.7)

Recipient HCV Positive (Yes/No)

2198 (5.6)

5743 (13.6)

Donor CMV Positive (Yes/No)

23,552 (57.1)

1620 (3.8)

Pretransplant dialysis (Yes/No)

31,046 (86)

284 (0.8)

Rejection (Yes/No)

8335 (19.8)

0

Cause of ESRD (vs. all others)

  

Diabetes

7862 (19.7)

5178 (12.3%)

Hypertension

5495 (13.2)

5178 (12.3%)

Maintenance Medications

  

Cyclosporine (vs. Tacrolimus)

31,448 (74.7)

3372 (8)

Tacrolimus (vs. Cyclosporine)

4623 (11.9)

3372 (8)

Mycophenolate (vs. Azathioprine)

18,608 (47.9)

3221 (7.6)

Azathioprine (vs. Mycophenolate)

16,308 (41.9)

3157 (7.5)

Prednisone (vs. all others)

34,451 (90.1)

3880 (9.2)

Induction Antibody Therapy

11,905 (28.3)

2277 (5.4)

Employment Status

  

Working Full time

14,714

 

Working Part time by choice

858

 

Working Part time due to disease

2012

 

Working part time reason unknown

200

 

Not working

13,833

 

Retired

2940

 

Missing or unknown

7539

 
  1. Data given as the number (% of total) mean ± one standard deviation A = followup time truncated at three years post transplant ESRD = end-stage renal disease B = time-dependent variable